Loading...
Drugs for improving esophageal mucosa defense: where are we now and where are we going?
In the past, the attention of physiologists and doctors has been mainly focused on the key role of acid in the pathogenesis of gastroesophageal reflux disease (GERD), but increasing evidence that 20-40% of reflux patients respond not at all or only partially to proton pump inhibitors (PPIs) has unde...
Na minha lista:
| Udgivet i: | Ann Gastroenterol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hellenic Society of Gastroenterology
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5670277/ https://ncbi.nlm.nih.gov/pubmed/29118552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2017.0187 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|